Today: 8 June 2026
Browse Category

HKG:2378 9 December 2025 - 17 December 2025

Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc (PRU) confirms ICICI Prudential AMC IPO underwriting as capital returns stay in focus — shares touch fresh 52‑week high (17.12.2025)

Prudential plc confirmed the underwriting agreement and final prospectus filing for the ICICI Prudential Asset Management IPO, with gross proceeds of about INR 106.03 billion expected. The company repurchased 773,817 shares for cancellation on 16 December. Shares hit a new 52-week high of 1,132p intraday on 17 December in London trading.
17 December 2025
···
Prudential plc Stock News Today (12 December 2025): PRU Shares Steady as ICICI Prudential AMC IPO Opens, Buyback Continues, Analysts Lift Targets

Prudential plc Stock News Today (12 December 2025): PRU Shares Steady as ICICI Prudential AMC IPO Opens, Buyback Continues, Analysts Lift Targets

Prudential plc’s London shares closed near 1,093p on 12 December 2025, close to a 52-week high, after the ICICI Prudential Asset Management IPO opened in India. Prudential confirmed it sold a 4.5% stake pre-IPO for about $536 million and plans to return proceeds to shareholders. The stock traded between 1,088.5p and 1,105p during the session. IPAMC’s IPO is set to close on 16 December.
12 December 2025
···
Prudential plc (LON: PRU) Stock Update – Share Price, India JV IPO, Buybacks and 2025 Forecast as of 9 December 2025

Prudential plc (LON: PRU) Stock Update – Share Price, India JV IPO, Buybacks and 2025 Forecast as of 9 December 2025

Prudential plc shares closed at about 1,098p in London on December 8, up roughly 66% over the past year. The surge follows strong Asian growth, a major share buyback, and news that its India joint venture, ICICI Prudential AMC, will launch an IPO on December 12. Fitch and S&P upgraded Prudential’s ratings, though analysts warn of execution and regulatory risks.
9 December 2025
····

Stock Market Today

  • Zealand Pharma Shares Drop 20% After Trial Users Quit Weight-Loss Drug
    June 8, 2026, 4:55 AM EDT. Zealand Pharma's stock fell 20% in Copenhagen trading after the company reported that 20% of participants in a trial of its weight-loss drug stopped treatment due to gastrointestinal side effects. The high dropout rate raised concerns over the drug's tolerability, prompting investor caution. Zealand Pharma's announcement highlighted challenges in retaining patients during clinical trials, a key factor influencing the drug's market potential and future sales. The decline underscores the sensitivity of biotech stocks to trial outcomes and patient adherence issues.

Latest articles

Nokia drops after fast AI rally, traders stay focused

Nokia rally stalls as traders sell tech stocks after AI push

8 June 2026
Nokia shares plunged 2.98% in Helsinki to 12.690 euros, extending losses as investors dumped AI-linked tech stocks amid rising oil prices and rate fears; U.S. ADRs dropped 13.48% Friday, while no new operating update was given and Nokia issued 500 million euros in new debt, with the next key earnings test set for July 23.
SpaceX Sets IPO at $135, Retail Buzz Ahead of SPCX Nasdaq Debut

SpaceX Sets IPO at $135, Retail Buzz Ahead of SPCX Nasdaq Debut

8 June 2026
SpaceX’s $75 billion IPO launches June 12 at $135 a share, with retail demand already double the shares on offer and 30% of the deal earmarked for individuals, but 2025 losses of $4.94 billion and a $1.75 trillion target valuation raise questions about post-IPO pricing as index entry and profitability remain uncertain.
Eli Lilly Set for Key Monday After New Weight-Loss Drug Data

Eli Lilly Set for Key Monday After New Weight-Loss Drug Data

8 June 2026
Eli Lilly closed at $1,131.42, up 0.55%, after releasing late-stage data showing its obesity drug retatrutide led to 28.3% weight loss over 80 weeks and reduced sleep apnea and knee pain, fueling hopes its obesity pipeline could expand beyond weight loss as rivals Boehringer Ingelheim and Zealand Pharma unveiled competing data, setting up a key test for Lilly’s trillion-dollar valuation as trading resumes.
SK Hynix Slips Even After Nvidia Deal as Korean AI Shares Slide

SK Hynix Slips Even After Nvidia Deal as Korean AI Shares Slide

8 June 2026
SK Hynix plunged 7.68% to 1,911,000 won despite sealing a multi-year Nvidia memory deal, as fears of a U.S. rate hike and a tech stock rout triggered circuit breakers and an 8.3% KOSPI crash, overshadowing strong AI demand and ongoing HBM supply constraints.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 08.06.2026

8 June 2026
LIVEMarkets rolling coverageStarted: June 8, 2026, 4:00 AM EDTUpdated: June 8, 2026, 4:56 AM EDT SpaceX IPO and Inflation Data Key Market Events This Week June 8, 2026, 4:56 AM EDT. Investors focus on SpaceX’s anticipated Nasdaq debut, potentially the largest initial public offering (IPO) ever. Market watchers also await key U.S. inflation data, which could influence Federal Reserve policy and financial markets. Apple’s developer conference will draw attention for its impact on tech stocks. These developments may drive trading volumes and volatility, providing critical cues for market direction. SpaceX IPO, Inflation Report: What to Watch This Week Zealand Pharma
Go toTop